John Kenneth Rose - Publications

Affiliations: 
1978-1986 Salk Institute for Biological Studies, La Jolla, CA, United States 
 1986- Pathology and Cell Biology Yale University School of Medicine, New Haven, CT 
Area:
Molecular Virology
Website:
http://people.yale.edu/search/john_rose.profile

157 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Chiale C, Yarovinsky TO, Mason SW, Madina BR, Menon M, Krady MM, Moshkani S, Chattopadhyay Pal A, Almassian B, Rose JK, Robek MD, Nakaar V. Modified Alphavirus-Vesiculovirus Hybrid Vaccine Vectors for Homologous Prime-Boost Immunotherapy of Chronic Hepatitis B. Vaccines. 8. PMID 32517032 DOI: 10.3390/Vaccines8020279  0.477
2020 Lo MK, Spengler JR, Krumpe LRH, Welch SR, Chattopadhyay A, Harmon JR, Coleman-McCray JD, Scholte FEM, Hotard AL, Fuqua JL, Rose JK, Nichol ST, Palmer KE, O'Keefe BR, Spiropoulou CF. Griffithsin Inhibits Nipah Virus Entry and Fusion and Can Protect Syrian Golden Hamsters From Lethal Nipah Virus Challenge. The Journal of Infectious Diseases. PMID 32037447 DOI: 10.1093/Infdis/Jiz630  0.429
2019 Yarovinsky TO, Mason SW, Menon M, Krady MM, Haslip M, Madina BR, Ma X, Moshkani S, Chiale C, Pal AC, Almassian B, Rose JK, Robek MD, Nakaar V. Virus-like Vesicles Expressing Multiple Antigens for Immunotherapy of Chronic Hepatitis B. Iscience. 21: 391-402. PMID 31704650 DOI: 10.1016/J.Isci.2019.10.040  0.349
2019 Chiale C, Moshkani S, Rose JK, Robek MD. Heterologous prime-boost immunization with vesiculovirus-based vectors expressing HBV core antigen induces CD8 T cell responses in naïve and persistently infected mice and protects from challenge. Antiviral Research. PMID 31153968 DOI: 10.1016/J.Antiviral.2019.05.014  0.446
2018 Moshkani S, Chiale C, Lang SM, Rose JK, Robek MD. A highly attenuated vesicular stomatitis virus-based vaccine platform controls HBV replication in mouse models of hepatitis B. Journal of Virology. PMID 30541859 DOI: 10.1128/Jvi.01586-18  0.473
2018 Chattopadhyay A, Aguilar PV, Bopp NE, Yarovinsky TO, Weaver SC, Rose JK. A recombinant virus vaccine that protects against both Chikungunya and Zika virus infections. Vaccine. PMID 29807712 DOI: 10.1016/J.Vaccine.2018.05.095  0.481
2017 Baquero E, Albertini AA, Raux H, Abou-Hamdan A, Boeri-Erba E, Ouldali M, Buonocore L, Rose JK, Lepault J, Bressanelli S, Gaudin Y. Structural intermediates in the fusion-associated transition of vesiculovirus glycoprotein. The Embo Journal. 36: 679-692. PMID 28188244 DOI: 10.15252/Embj.201694565  0.349
2017 van den Pol AN, Mao G, Chattopadhyay A, Rose JK, Davis JN. Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain. Journal of Virology. 91. PMID 28077641 DOI: 10.1128/Jvi.02154-16  0.437
2017 Okuma K, Fukagawa K, Kohma T, Takahama Y, Hamaguchi Y, Ito M, Tanaka Y, Buonocore L, Rose JK, Hamaguchi I. A recombinant vesicular stomatitis virus encoding CCR5-tropic HIV-1 receptors targets HIV-1-infected cells and controls HIV-1 infection. Microbes and Infection. 19: 277-287. PMID 28025070 DOI: 10.1016/J.Micinf.2016.12.004  0.354
2016 Clarke DK, Hendry RM, Singh V, Rose JK, Seligman SJ, Klug B, Kochhar S, Mac LM, Carbery B, Chen RT. Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment. Vaccine. 34: 6597-6609. PMID 27395563 DOI: 10.1016/J.Vaccine.2016.06.071  0.46
2016 Lauretti F, Chattopadhyay A, de Oliveira França RF, Castro-Jorge L, Rose J, da Fonseca BA. Recombinant Vesicular Stomatitis Virus-Based Dengue-2 Vaccine Candidate Induces Humoral Response and Protects Mice Against Lethal Infection. Human Vaccines & Immunotherapeutics. 0. PMID 27185081 DOI: 10.1080/21645515.2016.1183857  0.498
2015 Nachbagauer R, Miller MS, Hai R, Ryder AB, Rose JK, Palese P, García-Sastre A, Krammer F, Albrecht RA. Hemagglutinin Stalk Immunity Reduces Influenza Virus Replication and Transmission in Ferrets. Journal of Virology. 90: 3268-73. PMID 26719251 DOI: 10.1128/Jvi.02481-15  0.471
2015 Ryder AB, Nachbagauer R, Buonocore L, Palese P, Krammer F, Rose JK. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains. Journal of Virology. 90: 2544-50. PMID 26676789 DOI: 10.1128/Jvi.02598-15  0.445
2015 Reynolds TD, Buonocore L, Rose NF, Rose JK, Robek MD. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection. Journal of Virology. 89: 10407-15. PMID 26246574 DOI: 10.1128/Jvi.01184-15  0.496
2015 Baquero E, Albertini AA, Raux H, Buonocore L, Rose JK, Bressanelli S, Gaudin Y. Structure of the low pH conformation of Chandipura virus G reveals important features in the evolution of the vesiculovirus glycoprotein. Plos Pathogens. 11: e1004756. PMID 25803715 DOI: 10.1371/Journal.Ppat.1004756  0.37
2015 Okuma K, Fukagawa K, Tateyama S, Kohma T, Mochida K, Hiyoshi M, Takahama Y, Hamaguchi Y, Hirose K, Buonocore L, Rose JK, Mizuochi T, Hamaguchi I. Development of an infectious surrogate hepatitis C virus based on a recombinant vesicular stomatitis virus expressing hepatitis C virus envelope glycoproteins and green fluorescent protein. Japanese Journal of Infectious Diseases. 68: 203-8. PMID 25672345 DOI: 10.7883/Yoken.Jjid.2014.328  0.333
2015 Schell JB, Bahl K, Folta-Stogniew E, Rose N, Buonocore L, Marx PA, Gambhira R, Rose JK. Antigenic requirement for Gag in a vaccine that protects against high-dose mucosal challenge with simian immunodeficiency virus. Virology. 476: 405-12. PMID 25591175 DOI: 10.1016/J.Virol.2014.12.027  0.478
2015 Ryder AB, Buonocore L, Vogel L, Nachbagauer R, Krammer F, Rose JK. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine. Journal of Virology. 89: 2820-30. PMID 25540378 DOI: 10.1128/Jvi.03246-14  0.478
2014 Rose NF, Buonocore L, Schell JB, Chattopadhyay A, Bahl K, Liu X, Rose JK. In vitro evolution of high-titer, virus-like vesicles containing a single structural protein. Proceedings of the National Academy of Sciences of the United States of America. 111: 16866-71. PMID 25385608 DOI: 10.1073/Pnas.1414991111  0.477
2014 Gambhira R, Keele BF, Schell JB, Hunter MJ, Dufour JP, Montefiori DC, Tang H, Rose JK, Rose N, Marx PA. Transmitted/founder simian immunodeficiency virus envelope sequences in vesicular stomatitis and Semliki forest virus vector immunized rhesus macaques. Plos One. 9: e109678. PMID 25360552 DOI: 10.1371/Journal.Pone.0109678  0.48
2014 Krammer F, Hai R, Yondola M, Tan GS, Leyva-Grado VH, Ryder AB, Miller MS, Rose JK, Palese P, García-Sastre A, Albrecht RA. Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets. Journal of Virology. 88: 3432-42. PMID 24403585 DOI: 10.1128/Jvi.03004-13  0.466
2014 Lo MK, Bird BH, Chattopadhyay A, Drew CP, Martin BE, Coleman JD, Rose JK, Nichol ST, Spiropoulou CF. Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters. Antiviral Research. 101: 26-9. PMID 24184127 DOI: 10.1016/J.Antiviral.2013.10.012  0.467
2013 Talekar A, DeVito I, Salah Z, Palmer SG, Chattopadhyay A, Rose JK, Xu R, Wilson IA, Moscona A, Porotto M. Identification of a region in the stalk domain of the nipah virus receptor binding protein that is critical for fusion activation. Journal of Virology. 87: 10980-96. PMID 23903846 DOI: 10.1128/Jvi.01646-13  0.39
2013 Chattopadhyay A, Wang E, Seymour R, Weaver SC, Rose JK. A chimeric vesiculo/alphavirus is an effective alphavirus vaccine. Journal of Virology. 87: 395-402. PMID 23077320 DOI: 10.1128/Jvi.01860-12  0.493
2012 Baquero E, Buonocore L, Rose JK, Bressanelli S, Gaudin Y, Albertini AA. Crystallization and preliminary X-ray analysis of Chandipura virus glycoprotein G. Acta Crystallographica. Section F, Structural Biology and Crystallization Communications. 68: 1094-7. PMID 22949203 DOI: 10.1107/S1744309112030151  0.369
2012 Schell JB, Bahl K, Rose NF, Buonocore L, Hunter M, Marx PA, LaBranche CC, Montefiori DC, Rose JK. Viral vectored granulocyte-macrophage colony stimulating factor inhibits vaccine protection in an SIV challenge model: protection correlates with neutralizing antibody. Vaccine. 30: 4233-9. PMID 22537983 DOI: 10.1016/J.Vaccine.2012.04.046  0.494
2011 Schell JB, Rose NF, Bahl K, Diller K, Buonocore L, Hunter M, Marx PA, Gambhira R, Tang H, Montefiori DC, Johnson WE, Rose JK. Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen. Journal of Virology. 85: 5764-72. PMID 21490100 DOI: 10.1128/Jvi.00342-11  0.524
2011 Marthas ML, Van Rompay KK, Abbott Z, Earl P, Buonocore-Buzzelli L, Moss B, Rose NF, Rose JK, Kozlowski PA, Abel K. Partial efficacy of a VSV-SIV/MVA-SIV vaccine regimen against oral SIV challenge in infant macaques. Vaccine. 29: 3124-37. PMID 21377510 DOI: 10.1016/J.Vaccine.2011.02.051  0.452
2011 Schwartz JA, Buonocore L, Suguitan A, Hunter M, Marx PA, Subbarao K, Rose JK. Vesicular stomatitis virus-based H5N1 avian influenza vaccines induce potent cross-clade neutralizing antibodies in rhesus macaques. Journal of Virology. 85: 4602-5. PMID 21325423 DOI: 10.1128/Jvi.02491-10  0.436
2011 Chattopadhyay A, Rose JK. Complementing defective viruses that express separate paramyxovirus glycoproteins provide a new vaccine vector approach. Journal of Virology. 85: 2004-11. PMID 21177820 DOI: 10.1128/Jvi.01852-10  0.531
2010 Cobleigh MA, Buonocore L, Uprichard SL, Rose JK, Robek MD. A vesicular stomatitis virus-based hepatitis B virus vaccine vector provides protection against challenge in a single dose. Journal of Virology. 84: 7513-22. PMID 20504927 DOI: 10.1128/Jvi.00200-10  0.501
2010 Schwartz JA, Buonocore L, Suguitan AL, Silaghi A, Kobasa D, Kobinger G, Feldmann H, Subbarao K, Rose JK. Potent vesicular stomatitis virus-based avian influenza vaccines provide long-term sterilizing immunity against heterologous challenge. Journal of Virology. 84: 4611-8. PMID 20181720 DOI: 10.1128/Jvi.02637-09  0.452
2010 Simon ID, van Rooijen N, Rose JK. Vesicular stomatitis virus genomic RNA persists in vivo in the absence of viral replication. Journal of Virology. 84: 3280-6. PMID 20032173 DOI: 10.1128/Jvi.02052-09  0.787
2010 Van Rompay KK, Abel K, Earl P, Kozlowski PA, Easlick J, Moore J, Buonocore-Buzzelli L, Schmidt KA, Wilson RL, Simon I, Moss B, Rose N, Rose J, Marthas ML. Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV. Vaccine. 28: 1481-92. PMID 19995539 DOI: 10.1016/J.Vaccine.2009.11.061  0.809
2010 Wollmann G, Rogulin V, Simon I, Rose JK, van den Pol AN. Some attenuated variants of vesicular stomatitis virus show enhanced oncolytic activity against human glioblastoma cells relative to normal brain cells. Journal of Virology. 84: 1563-73. PMID 19906910 DOI: 10.1128/Jvi.02040-09  0.785
2010 Brandsma JL, Shlyankevich M, Su Y, Zelterman D, Rose JK, Buonocore L. Reversal of papilloma growth in rabbits therapeutically vaccinated against E6 with naked DNA and/or vesicular stomatitis virus vectors. Vaccine. 28: 8345-51. PMID 19615481 DOI: 10.1016/J.Vaccine.2009.04.082  0.42
2009 van den Pol AN, Ozduman K, Wollmann G, Ho WS, Simon I, Yao Y, Rose JK, Ghosh P. Viral strategies for studying the brain, including a replication-restricted self-amplifying delta-G vesicular stomatis virus that rapidly expresses transgenes in brain and can generate a multicolor golgi-like expression. The Journal of Comparative Neurology. 516: 456-81. PMID 19672982 DOI: 10.1002/Cne.22131  0.799
2009 Detje CN, Meyer T, Schmidt H, Kreuz D, Rose JK, Bechmann I, Prinz M, Kalinke U. Local type I IFN receptor signaling protects against virus spread within the central nervous system. Journal of Immunology (Baltimore, Md. : 1950). 182: 2297-304. PMID 19201884 DOI: 10.4049/Jimmunol.0800596  0.427
2009 Schell J, Rose NF, Fazo N, Marx PA, Hunter M, Ramsburg E, Montefiori D, Earl P, Moss B, Rose JK. Long-term vaccine protection from AIDS and clearance of viral DNA following SHIV89.6P challenge. Vaccine. 27: 979-86. PMID 19135115 DOI: 10.1016/J.Vaccine.2008.12.017  0.474
2008 Chattopadhyay A, Park S, Delmas G, Suresh R, Senina S, Perlin DS, Rose JK. Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection. Vaccine. 26: 6329-37. PMID 18832004 DOI: 10.1016/J.Vaccine.2008.09.031  0.47
2008 Wilson SR, Wilson JH, Buonocore L, Palin A, Rose JK, Reuter JD. Intranasal immunization with recombinant vesicular stomatitis virus expressing murine cytomegalovirus glycoprotein B induces humoral and cellular immunity. Comparative Medicine. 58: 129-39. PMID 18524170  0.402
2008 Kapadia SU, Simon ID, Rose JK. SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector. Virology. 376: 165-72. PMID 18396306 DOI: 10.1016/J.Virol.2008.03.002  0.799
2008 Rose NF, Publicover J, Chattopadhyay A, Rose JK. Hybrid alphavirus-rhabdovirus propagating replicon particles are versatile and potent vaccine vectors. Proceedings of the National Academy of Sciences of the United States of America. 105: 5839-43. PMID 18391206 DOI: 10.1073/Pnas.0800280105  0.8
2008 Liao JB, Publicover J, Rose JK, DiMaio D. Single-dose, therapeutic vaccination of mice with vesicular stomatitis virus expressing human papillomavirus type 16 E7 protein. Clinical and Vaccine Immunology : Cvi. 15: 817-24. PMID 18337377 DOI: 10.1128/Cvi.00343-07  0.752
2008 Abel K, Van Rompay KK, Eastlick J, Moore J, Lemieux M, Schmidt K, Earl P, Buonocore-Buzzelli L, Moss B, Rose N, Rose J, McChesney MB, Kozlowski P, Marthas ML. VSV/MVA vaccine rapidly elicits SIV antibodies and local and systemic SIV T cell responses in macaque neonates but does not prevent SIV dissemination after oral challenge Retrovirology. 5: O15. DOI: 10.1186/1742-4690-5-S1-O15  0.38
2007 Schwartz JA, Buonocore L, Roberts A, Suguitan A, Kobasa D, Kobinger G, Feldmann H, Subbarao K, Rose JK. Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection. Virology. 366: 166-73. PMID 17524441 DOI: 10.1016/J.Virol.2007.04.021  0.474
2007 Ramsburg EA, Publicover JM, Coppock D, Rose JK. Requirement for CD4 T cell help in maintenance of memory CD8 T cell responses is epitope dependent. Journal of Immunology (Baltimore, Md. : 1950). 178: 6350-8. PMID 17475864 DOI: 10.4049/Jimmunol.178.10.6350  0.752
2007 Brandsma JL, Shylankevich M, Su Y, Roberts A, Rose JK, Zelterman D, Buonocore L. Vesicular stomatitis virus-based therapeutic vaccination targeted to the E1, E2, E6, and E7 proteins of cottontail rabbit papillomavirus. Journal of Virology. 81: 5749-58. PMID 17392369 DOI: 10.1128/Jvi.02835-06  0.412
2007 Vogel LN, Roberts A, Paddock CD, Genrich GL, Lamirande EW, Kapadia SU, Rose JK, Zaki SR, Subbarao K. Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for severe acute respiratory syndrome coronavirus (SARS-CoV). Vaccine. 25: 2173-9. PMID 17227689 DOI: 10.1016/J.Vaccine.2006.11.055  0.786
2007 Simon ID, Publicover J, Rose JK. Replication and propagation of attenuated vesicular stomatitis virus vectors in vivo: vector spread correlates with induction of immune responses and persistence of genomic RNA. Journal of Virology. 81: 2078-82. PMID 17151110 DOI: 10.1128/Jvi.02525-06  0.788
2007 Brandsma JL, Shlyankevich M, Buonocore L, Roberts A, Becker SM, Rose JK. Therapeutic efficacy of vesicular stomatitis virus-based E6 vaccination in rabbits. Vaccine. 25: 751-62. PMID 16962690 DOI: 10.1016/J.Vaccine.2006.08.012  0.382
2007 Palin A, Chattopadhyay A, Park S, Delmas G, Suresh R, Senina S, Perlin DS, Rose JK. An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge. Vaccine. 25: 741-50. PMID 16959385 DOI: 10.1016/J.Vaccine.2006.08.010  0.48
2006 Publicover J, Ramsburg E, Robek M, Rose JK. Rapid pathogenesis induced by a vesicular stomatitis virus matrix protein mutant: viral pathogenesis is linked to induction of tumor necrosis factor alpha. Journal of Virology. 80: 7028-36. PMID 16809308 DOI: 10.1128/Jvi.00478-06  0.729
2006 Okuma K, Boritz E, Walker J, Sarkar A, Alexander L, Rose JK. Recombinant vesicular stomatitis viruses encoding simian immunodeficiency virus receptors target infected cells and control infection. Virology. 346: 86-97. PMID 16325218 DOI: 10.1016/J.Virol.2005.10.041  0.411
2005 Ramsburg E, Publicover J, Buonocore L, Poholek A, Robek M, Palin A, Rose JK. A vesicular stomatitis virus recombinant expressing granulocyte-macrophage colony-stimulating factor induces enhanced T-cell responses and is highly attenuated for replication in animals. Journal of Virology. 79: 15043-53. PMID 16306575 DOI: 10.1128/Jvi.79.24.15043-15053.2005  0.799
2005 Publicover J, Ramsburg E, Rose JK. A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector. Journal of Virology. 79: 13231-8. PMID 16227246 DOI: 10.1128/Jvi.79.21.13231-13238.2005  0.814
2005 Egan MA, Chong SY, Megati S, Montefiori DC, Rose NF, Boyer JD, Sidhu MK, Quiroz J, Rosati M, Schadeck EB, Pavlakis GN, Weiner DB, Rose JK, Israel ZR, Udem SA, et al. Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus. Aids Research and Human Retroviruses. 21: 629-43. PMID 16060834 DOI: 10.1089/Aid.2005.21.629  0.476
2005 Kapadia SU, Rose JK, Lamirande E, Vogel L, Subbarao K, Roberts A. Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine. Virology. 340: 174-82. PMID 16043204 DOI: 10.1016/J.Virol.2005.06.016  0.809
2004 Egan MA, Chong SY, Rose NF, Megati S, Lopez KJ, Schadeck EB, Johnson JE, Masood A, Piacente P, Druilhet RE, Barras PW, Hasselschwert DL, Reilly P, Mishkin EM, Montefiori DC, ... ... Rose JK, et al. Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routes. Aids Research and Human Retroviruses. 20: 989-1004. PMID 15585086 DOI: 10.1089/Aid.2004.20.989  0.473
2004 Publicover J, Ramsburg E, Rose JK. Characterization of nonpathogenic, live, viral vaccine vectors inducing potent cellular immune responses. Journal of Virology. 78: 9317-24. PMID 15308726 DOI: 10.1128/Jvi.78.17.9317-9324.2004  0.792
2004 Schlehuber LD, Rose JK. Prediction and identification of a permissive epitope insertion site in the vesicular stomatitis virus glycoprotein. Journal of Virology. 78: 5079-87. PMID 15113889 DOI: 10.1128/Jvi.78.10.5079-5087.2004  0.787
2004 Ramsburg E, Rose NF, Marx PA, Mefford M, Nixon DF, Moretto WJ, Montefiori D, Earl P, Moss B, Rose JK. Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol. Journal of Virology. 78: 3930-40. PMID 15047809 DOI: 10.1128/Jvi.78.8.3930-3940.2004  0.527
2004 Roberts A, Reuter JD, Wilson JH, Baldwin S, Rose JK. Complete protection from papillomavirus challenge after a single vaccination with a vesicular stomatitis virus vector expressing high levels of L1 protein. Journal of Virology. 78: 3196-9. PMID 14990742 DOI: 10.1128/Jvi.78.6.3196-3199.2004  0.424
2003 Schlereth B, Buonocore L, Tietz A, Meulen Vt Vt, Rose JK, Niewiesk S. Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus dose. The Journal of General Virology. 84: 2145-51. PMID 12867646 DOI: 10.1099/Vir.0.19050-0  0.436
2003 Okuma K, Dalton KP, Buonocore L, Ramsburg E, Rose JK. Development of a novel surrogate virus for human T-cell leukemia virus type 1: inhibition of infection by osteoprotegerin. Journal of Virology. 77: 8562-9. PMID 12857926 DOI: 10.1128/Jvi.77.15.8562-8569.2003  0.494
2002 Reuter JD, Vivas-Gonzalez BE, Gomez D, Wilson JH, Brandsma JL, Greenstone HL, Rose JK, Roberts A. Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced disease. Journal of Virology. 76: 8900-9. PMID 12163609 DOI: 10.1128/Jvi.76.17.8900-8909.2002  0.405
2002 Haglund K, Leiner I, Kerksiek K, Buonocore L, Pamer E, Rose JK. Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type 1 Gag and Env proteins. Journal of Virology. 76: 7506-17. PMID 12097563 DOI: 10.1128/Jvi.76.15.7506-7517.2002  0.767
2002 Buonocore L, Blight KJ, Rice CM, Rose JK. Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins. Journal of Virology. 76: 6865-72. PMID 12072487 DOI: 10.1128/Jvi.76.14.6865-6872.2002  0.458
2002 Quiñones-Kochs MI, Buonocore L, Rose JK. Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response. Journal of Virology. 76: 4199-211. PMID 11932385 DOI: 10.1128/Jvi.76.9.4199-4211.2002  0.755
2002 Haglund K, Leiner I, Kerksiek K, Buonocore L, Pamer E, Rose JK. High-level primary CD8(+) T-cell response to human immunodeficiency virus type 1 gag and env generated by vaccination with recombinant vesicular stomatitis viruses. Journal of Virology. 76: 2730-8. PMID 11861840 DOI: 10.1128/Jvi.76.6.2730-2738.2002  0.78
2002 van den Pol AN, Dalton KP, Rose JK. Relative neurotropism of a recombinant rhabdovirus expressing a green fluorescent envelope glycoprotein. Journal of Virology. 76: 1309-27. PMID 11773406 DOI: 10.1128/Jvi.76.3.1309-1327.2002  0.384
2001 Kahn JS, Roberts A, Weibel C, Buonocore L, Rose JK. Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge. Journal of Virology. 75: 11079-87. PMID 11602747 DOI: 10.1128/Jvi.75.22.11079-11087.2001  0.452
2001 Reuter JD, Gomez D, Brandsma JL, Rose JK, Roberts A. Optimization of cottontail rabbit papilloma virus challenge technique. Journal of Virological Methods. 98: 127-34. PMID 11576639 DOI: 10.1016/S0166-0934(01)00370-6  0.359
2001 Rose NF, Marx PA, Luckay A, Nixon DF, Moretto WJ, Donahoe SM, Montefiori D, Roberts A, Buonocore L, Rose JK. An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell. 106: 539-49. PMID 11551502 DOI: 10.1016/S0092-8674(01)00482-2  0.483
2001 Quiñones-Kochs MI, Schnell MJ, Buonocore L, Rose JK. Mechanisms of loss of foreign gene expression in recombinant vesicular stomatitis viruses. Virology. 287: 427-35. PMID 11531419 DOI: 10.1006/Viro.2001.1058  0.433
2001 Dalton KP, Rose JK. Vesicular stomatitis virus glycoprotein containing the entire green fluorescent protein on its cytoplasmic domain is incorporated efficiently into virus particles. Virology. 279: 414-21. PMID 11162797 DOI: 10.1006/Viro.2000.0736  0.451
2000 Rose NF, Roberts A, Buonocore L, Rose JK. Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1. Journal of Virology. 74: 10903-10. PMID 11069984 DOI: 10.1128/Jvi.74.23.10903-10910.2000  0.512
2000 Grigera PR, Marzocca MP, Capozzo AV, Buonocore L, Donis RO, Rose JK. Presence of bovine viral diarrhea virus (BVDV) E2 glycoprotein in VSV recombinant particles and induction of neutralizing BVDV antibodies in mice. Virus Research. 69: 3-15. PMID 10989181 DOI: 10.1016/S0168-1702(00)00164-7  0.312
2000 Schlereth B, Rose JK, Buonocore L, ter Meulen V, Niewiesk S. Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies. Journal of Virology. 74: 4652-7. PMID 10775601 DOI: 10.1128/Jvi.74.10.4652-4657.2000  0.384
2000 Haglund K, Forman J, Kräusslich HG, Rose JK. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope. Virology. 268: 112-21. PMID 10683333 DOI: 10.1006/Viro.1999.0120  0.756
1999 Roberts A, Rose JK. Redesign and genetic dissection of the rhabdoviruses. Advances in Virus Research. 53: 301-19. PMID 10582104 DOI: 10.1016/S0065-3527(08)60353-X  0.452
1999 Boritz E, Gerlach J, Johnson JE, Rose JK. Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway. Journal of Virology. 73: 6937-45. PMID 10400792 DOI: 10.1128/Jvi.73.8.6937-6945.1999  0.444
1999 Roberts A, Buonocore L, Price R, Forman J, Rose JK. Attenuated vesicular stomatitis viruses as vaccine vectors. Journal of Virology. 73: 3723-32. PMID 10196265 DOI: 10.1128/Jvi.73.5.3723-3732.1999  0.495
1999 Kahn JS, Schnell MJ, Buonocore L, Rose JK. Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion. Virology. 254: 81-91. PMID 9927576 DOI: 10.1006/Viro.1998.9535  0.46
1998 Johnson JE, Rodgers W, Rose JK. A plasma membrane localization signal in the HIV-1 envelope cytoplasmic domain prevents localization at sites of vesicular stomatitis virus budding and incorporation into VSV virions. Virology. 251: 244-52. PMID 9837788 DOI: 10.1006/Viro.1998.9429  0.448
1998 Kim SK, Reed DS, Olson S, Schnell MJ, Rose JK, Morton PA, Lefrançois L. Generation of mucosal cytotoxic T cells against soluble protein by tissue-specific environmental and costimulatory signals. Proceedings of the National Academy of Sciences of the United States of America. 95: 10814-9. PMID 9724787 DOI: 10.1073/Pnas.95.18.10814  0.356
1998 Roberts A, Kretzschmar E, Perkins AS, Forman J, Price R, Buonocore L, Kawaoka Y, Rose JK. Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge. Journal of Virology. 72: 4704-11. PMID 9573234 DOI: 10.1128/Jvi.72.6.4704-4711.1998  0.493
1998 Schnell MJ, Buonocore L, Boritz E, Ghosh HP, Chernish R, Rose JK. Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus. The Embo Journal. 17: 1289-96. PMID 9482726 DOI: 10.1093/Emboj/17.5.1289  0.423
1997 Schnell MJ, Johnson JE, Buonocore L, Rose JK. Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection. Cell. 90: 849-57. PMID 9298897 DOI: 10.1016/S0092-8674(00)80350-5  0.397
1997 Kretzschmar E, Buonocore L, Schnell MJ, Rose JK. High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses. Journal of Virology. 71: 5982-9. PMID 9223488 DOI: 10.1128/Jvi.71.8.5982-5989.1997  0.48
1997 Johnson JE, Schnell MJ, Buonocore L, Rose JK. Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins. Journal of Virology. 71: 5060-8. PMID 9188571 DOI: 10.1128/Jvi.71.7.5060-5068.1997  0.448
1996 Rose JK. Positive strands to the rescue again: a segmented negative-strand RNA virus derived from cloned cDNAs. Proceedings of the National Academy of Sciences of the United States of America. 93: 14998-5000. PMID 8986751 DOI: 10.1073/Pnas.93.26.14998  0.401
1996 Schnell MJ, Buonocore L, Kretzschmar E, Johnson E, Rose JK. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proceedings of the National Academy of Sciences of the United States of America. 93: 11359-65. PMID 8876140 DOI: 10.1073/Pnas.93.21.11359  0.469
1996 Kretzschmar E, Bui M, Rose JK. Membrane association of influenza virus matrix protein does not require specific hydrophobic domains or the viral glycoproteins. Virology. 220: 37-45. PMID 8659126 DOI: 10.1006/Viro.1996.0283  0.365
1996 Schnell MJ, Buonocore L, Whitt MA, Rose JK. The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus. Journal of Virology. 70: 2318-23. PMID 8642658 DOI: 10.1128/Jvi.70.4.2318-2323.1996  0.433
1996 Turi TG, Mueller UW, Sazer S, Rose JK. Characterization of a nuclear protein conferring brefeldin A resistance in Schizosaccharomyces pombe. The Journal of Biological Chemistry. 271: 9166-71. PMID 8621569 DOI: 10.1074/Jbc.271.15.9166  0.321
1996 Rolls MM, Haglund K, Rose JK. Expression of additional genes in a vector derived from a minimal RNA virus. Virology. 218: 406-11. PMID 8610469 DOI: 10.1006/Viro.1996.0211  0.824
1996 Kretzschmar E, Peluso R, Schnell MJ, Whitt MA, Rose JK. Normal replication of vesicular stomatitis virus without C proteins. Virology. 216: 309-16. PMID 8607260 DOI: 10.1006/Viro.1996.0066  0.44
1995 Lawson ND, Stillman EA, Whitt MA, Rose JK. Recombinant vesicular stomatitis viruses from DNA. Proceedings of the National Academy of Sciences of the United States of America. 92: 4477-81. PMID 7753828 DOI: 10.1073/Pnas.92.10.4477  0.428
1995 Stillman EA, Rose JK, Whitt MA. Replication and amplification of novel vesicular stomatitis virus minigenomes encoding viral structural proteins. Journal of Virology. 69: 2946-53. PMID 7707520 DOI: 10.1128/Jvi.69.5.2946-2953.1995  0.469
1995 Lawson ND, Stillman EA, Whitt MA, Rose JK. Corrections: Recombinant Vesicular Stomatitis Viruses from DNA Proceedings of the National Academy of Sciences of the United States of America. 92: 9009. DOI: 10.1073/Pnas.92.19.9009C  0.311
1994 Buonocore L, Turi TG, Crise B, Rose JK. Stimulation of heterologous protein degradation by the Vpu protein of HIV-1 requires the transmembrane and cytoplasmic domains of CD4. Virology. 204: 482-6. PMID 8091684 DOI: 10.1006/Viro.1994.1560  0.315
1994 Rodgers W, Crise B, Rose JK. Signals determining protein tyrosine kinase and glycosyl-phosphatidylinositol-anchored protein targeting to a glycolipid-enriched membrane fraction. Molecular and Cellular Biology. 14: 5384-91. PMID 8035816 DOI: 10.1128/Mcb.14.8.5384  0.307
1994 Rolls MM, Webster P, Balba NH, Rose JK. Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA. Cell. 79: 497-506. PMID 7954815 DOI: 10.1016/0092-8674(94)90258-5  0.707
1993 Buonocore L, Rose JK. Blockade of human immunodeficiency virus type 1 production in CD4+ T cells by an intracellular CD4 expressed under control of the viral long terminal repeat. Proceedings of the National Academy of Sciences of the United States of America. 90: 2695-9. PMID 8464877 DOI: 10.1073/PNAS.90.7.2695  0.305
1993 Doms RW, Lamb RA, Rose JK, Helenius A. Folding and assembly of viral membrane proteins. Virology. 193: 545-62. PMID 8460475 DOI: 10.1006/Viro.1993.1164  0.317
1993 Cattaneo R, Rose JK. Cell fusion by the envelope glycoproteins of persistent measles viruses which caused lethal human brain disease. Journal of Virology. 67: 1493-502. PMID 8437226 DOI: 10.1128/Jvi.67.3.1493-1502.1993  0.381
1993 Owens RJ, Rose JK. Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus. Journal of Virology. 67: 360-5. PMID 8093220 DOI: 10.1128/JVI.67.1.360-365.1993  0.308
1992 Brown DA, Rose JK. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell. 68: 533-44. PMID 1531449 DOI: 10.1016/0092-8674(92)90189-J  0.322
1992 Zhang F, Crise B, Su B, Hou Y, Rose JK, Bothwell A, Jacobson K. The lateral mobility of some membrane proteins is determined by their ectodomains. Biophysical Journal. 62: 92-4. PMID 1318107 DOI: 10.1016/S0006-3495(92)81789-7  0.495
1992 Kemble GW, Bodian DL, Rosé J, Wilson IA, White JM. Intermonomer disulfide bonds impair the fusion activity of influenza virus hemagglutinin. Journal of Virology. 66: 4940-4950. DOI: 10.1128/Jvi.66.8.4940-4950.1992  0.34
1991 Zagouras P, Ruusala A, Rose JK. Dissociation and reassociation of oligomeric viral glycoprotein subunits in the endoplasmic reticulum. Journal of Virology. 65: 1976-84. PMID 1848313 DOI: 10.1128/Jvi.65.4.1976-1984.1991  0.351
1991 Zhang F, Crise B, Su B, Hou Y, Rose JK, Bothwell A, Jacobson K. Lateral diffusion of membrane-spanning and glycosylphosphatidylinositol-linked proteins: toward establishing rules governing the lateral mobility of membrane proteins. The Journal of Cell Biology. 115: 75-84. PMID 1680869 DOI: 10.1083/Jcb.115.1.75  0.564
1991 Whitt MA, Rose JK. Fatty acid acylation is not required for membrane fusion activity or glycoprotein assembly into VSV virions. Virology. 185: 875-8. PMID 1660205 DOI: 10.1016/0042-6822(91)90563-Q  0.419
1991 Whitt MA, Buonocore L, Prehaud C, Rose JK. Membrane fusion activity, oligomerization, and assembly of the rabies virus glycoprotein. Virology. 185: 681-8. PMID 1660200 DOI: 10.1016/0042-6822(91)90539-N  0.442
1990 Crise B, Buonocore L, Rose JK. CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor. Journal of Virology. 64: 5585-93. PMID 2214026 DOI: 10.1128/Jvi.64.11.5585-5593.1990  0.328
1990 Buonocore L, Rose JK. Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum. Nature. 345: 625-8. PMID 2190096 DOI: 10.1038/345625A0  0.373
1990 Whitt MA, Zagouras P, Crise B, Rose JK. A fusion-defective mutant of the vesicular stomatitis virus glycoprotein. Journal of Virology. 64: 4907-13. PMID 2168975 DOI: 10.1128/Jvi.64.10.4907-4913.1990  0.462
1989 Zagouras P, Rose JK. Carboxy-terminal SEKDEL sequences retard but do not retain two secretory proteins in the endoplasmic reticulum. The Journal of Cell Biology. 109: 2633-40. PMID 2592401 DOI: 10.1083/Jcb.109.6.2633  0.332
1989 Shaw AS, Amrein KE, Hammond C, Stern DF, Sefton BM, Rose JK. The lck tyrosine protein kinase interacts with the cytoplasmic tail of the CD4 glycoprotein through its unique amino-terminal domain. Cell. 59: 627-36. PMID 2582490 DOI: 10.1016/0092-8674(89)90008-1  0.312
1989 Brown DA, Crise B, Rose JK. Mechanism of membrane anchoring affects polarized expression of two proteins in MDCK cells. Science (New York, N.Y.). 245: 1499-501. PMID 2571189 DOI: 10.1126/Science.2571189  0.356
1989 Crise B, Ruusala A, Zagouras P, Shaw A, Rose JK. Oligomerization of glycolipid-anchored and soluble forms of the vesicular stomatitis virus glycoprotein. Journal of Virology. 63: 5328-33. PMID 2555557 DOI: 10.1128/Jvi.63.12.5328-5333.1989  0.416
1989 Whitt MA, Chong L, Rose JK. Glycoprotein cytoplasmic domain sequences required for rescue of a vesicular stomatitis virus glycoprotein mutant. Journal of Virology. 63: 3569-78. PMID 2547986 DOI: 10.1128/Jvi.63.9.3569-3578.1989  0.436
1988 Shaw AS, Rottier PJ, Rose JK. Evidence for the loop model of signal-sequence insertion into the endoplasmic reticulum. Proceedings of the National Academy of Sciences of the United States of America. 85: 7592-6. PMID 2845415 DOI: 10.1073/Pnas.85.20.7592  0.314
1988 Guan JL, Ruusala A, Cao H, Rose JK. Effects of altered cytoplasmic domains on transport of the vesicular stomatitis virus glycoprotein are transferable to other proteins. Molecular and Cellular Biology. 8: 2869-74. PMID 2841589  0.508
1988 Doms RW, Ruusala A, Machamer C, Helenius J, Helenius A, Rose JK. Differential effects of mutations in three domains on folding, quaternary structure, and intracellular transport of vesicular stomatitis virus G protein. The Journal of Cell Biology. 107: 89-99. PMID 2839523 DOI: 10.1083/Jcb.107.1.89  0.383
1988 Fukuda M, Guan JL, Rose JK. A membrane-anchored form but not the secretory form of human chorionic gonadotropin-alpha chain acquires polylactosaminoglycan. The Journal of Biological Chemistry. 263: 5314-8. PMID 2451668  0.453
1988 Guan JL, Cao H, Rose JK. Cell-surface expression of a membrane-anchored form of the human chorionic gonadotropin alpha subunit. The Journal of Biological Chemistry. 263: 5306-13. PMID 2451667  0.494
1988 Whitt M, Doms R, Ruusala A, Helenius J, Helenius A, Rose J. Dual roles for the cytoplasmic domain of the VSV G protein: Protein transport and virus assembly Virus Research. 11: 6. DOI: 10.1016/0168-1702(88)90108-6  0.402
1985 Guan JL, Machamer CE, Rose JK. Glycosylation allows cell-surface transport of an anchored secretory protein. Cell. 42: 489-96. PMID 3928168 DOI: 10.1016/0092-8674(85)90106-0  0.494
1985 Moller JR, Rager-Zisman B, Quan PC, Schattner A, Panush D, Rose JK, Bloom BR. Natural killer cell recognition of target cells expressing different antigens of vesicular stomatitis virus. Proceedings of the National Academy of Sciences of the United States of America. 82: 2456-9. PMID 2986117 DOI: 10.1073/pnas.82.8.2456  0.342
1985 Mackett M, Yilma T, Rose JK, Moss B. Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle. Science (New York, N.Y.). 227: 433-5. PMID 2981435 DOI: 10.1126/Science.2981435  0.459
1984 Guan JL, Rose JK. Conversion of a secretory protein into a transmembrane protein results in its transport to the Golgi complex but not to the cell surface. Cell. 37: 779-87. PMID 6589049  0.49
1984 Rose JK, Adams GA, Gallione CJ. The presence of cysteine in the cytoplasmic domain of the vesicular stomatitis virus glycoprotein is required for palmitate addition. Proceedings of the National Academy of Sciences of the United States of America. 81: 2050-4. PMID 6326102 DOI: 10.1073/Pnas.81.7.2050  0.41
1983 Florkiewicz RZ, Smith A, Bergmann JE, Rose JK. Isolation of stable mouse cell lines that express cell surface and secreted forms of the vesicular stomatitis virus glycoprotein. The Journal of Cell Biology. 97: 1381-8. PMID 6415065 DOI: 10.1083/jcb.97.5.1381  0.327
1983 Rose JK, Bergmann JE. Altered cytoplasmic domains affect intracellular transport of the vesicular stomatitis virus glycoprotein. Cell. 34: 513-24. PMID 6352053 DOI: 10.1016/0092-8674(83)90384-7  0.305
1982 Rose JK, Bergmann JE. Expression from cloned cDNA of cell-surface secreted forms of the glycoprotein of vesicular stomatitis virus in eucaryotic cells. Cell. 30: 753-62. PMID 6291783 DOI: 10.1016/0092-8674(82)90280-X  0.325
1982 Rose JK, Doolittle RF, Anilionis A, Curtis PJ, Wunner WH. Homology between the glycoproteins of vesicular stomatitis virus and rabies virus. Journal of Virology. 43: 361-4. PMID 6287013 DOI: 10.1128/jvi.43.1.361-364.1982  0.32
1980 Trachsel H, Sonenberg N, Shatkin AJ, Rose JK, Leong K, Bergmann JE, Gordon J, Baltimore D. Purification of a factor that restores translation of vesicular stomatitis virus mRNA in extracts from poliovirus-infected HeLa cells. Proceedings of the National Academy of Sciences of the United States of America. 77: 770-4. PMID 6244584 DOI: 10.1073/Pnas.77.2.770  0.485
1978 Rose JK, Trachsel H, Leong K, Baltimore D. Inhibition of translation by poliovirus: inactivation of a specific initiation factor. Proceedings of the National Academy of Sciences of the United States of America. 75: 2732-6. PMID 208073 DOI: 10.1073/Pnas.75.6.2732  0.481
1977 Rose JK. Nucleotide sequences of ribosome recgonition sites in messenger RNAs of vesicular stomatitis virus. Proceedings of the National Academy of Sciences of the United States of America. 74: 3672-6. PMID 198795 DOI: 10.1073/Pnas.74.9.3672  0.342
1977 Pettersson RF, Flanegan JB, Rose JK, Baltimore D. 5'-Terminal nucleotide sequences of polio virus polyribosomal RNA and virion RNA are identical. Nature. 268: 270-2. PMID 196211 DOI: 10.1038/268270A0  0.442
1977 Rose JK, Lodish HF, Brock ML. Giant heterogeneous polyadenylic acid on vesicular stomatitis virus mRNA synthesized in vitro in the presence of S-adenosylhomocysteine. Journal of Virology. 21: 683-93. PMID 189093  0.42
1976 Rose JK, Haseltine WA, Baltimore D. 5'-terminus of Moloney murine leukemia virus 35s RNA is m7G5' ppp5' GmpCp. Journal of Virology. 20: 324-9. PMID 185415 DOI: 10.1128/Jvi.20.1.324-329.1976  0.621
1976 Rose JK, Lodish HF. Translation in vitro of vesicular stomatitis virus mRNA lacking 5'-terminal 7-methylguanosine. Nature. 262: 32-7. PMID 180425 DOI: 10.1038/262032A0  0.424
1976 Hewlett MJ, Rose JK, Baltimore D. 5'-terminal structure of poliovirus polyribosomal RNA is pUp. Proceedings of the National Academy of Sciences of the United States of America. 73: 327-30. PMID 174102 DOI: 10.1073/Pnas.73.2.327  0.466
1975 Rose JK, Knipe D. Nucleotide sequence complexities, molecular weights, and poly(A) content of the vesicular stomatitis virus mRNA species. Journal of Virology. 15: 994-1003. PMID 163928 DOI: 10.1128/Jvi.15.4.994-1003.1975  0.334
1975 Knipe D, Rose JK, Lodish HF. Translation of individual species of vesicular stomatitis viral mRNA. Journal of Virology. 15: 1004-11. PMID 163911 DOI: 10.1128/Jvi.15.4.1004-1011.1975  0.516
1975 Knipe D, Rose JK, Lodish HF. Translation of individual species of vesicular stomatitis viral mRNA. Journal of Virology. 15: 1004-1011. DOI: 10.1128/jvi.15.4.1004-1011.1975  0.402
1974 Rose JK, Yanofsky C. Interaction of the operator of the tryptophan operon with repressor. Proceedings of the National Academy of Sciences of the United States of America. 71: 3134-8. PMID 4528605 DOI: 10.1073/Pnas.71.8.3134  0.45
1973 Rose JK, Squires CL, Yanofsky C, Yang HL, Zubay G. Regulation of in vitro transcription of the tryptophan operon by purified RNA polymerase in the presence of partially purified repressor and tryptophan. Nature: New Biology. 245: 133-7. PMID 4582892 DOI: 10.1038/Newbio245133A0  0.677
1973 Squires CL, Rose JK, Yanofsky C, Yang HL, Zubay G. Tryptophanyl-tRNA and tryptophanyl-tRNA synthetase are not required for in vitro repression of the tryptophan operon. Nature: New Biology. 245: 131-3. PMID 4582891 DOI: 10.1038/Newbio245131A0  0.658
1972 Rose JK, Yanofsky C. Metabolic regulation of the tryptophan operon of Escherichia coli: repressor-independent regulation of transcription initiation frequency. Journal of Molecular Biology. 69: 103-18. PMID 4560758 DOI: 10.1016/0022-2836(72)90026-5  0.41
1971 Rose JK, Yanofsky C. Transcription of the operator proximal and distal ends of the tryptophan operon: evidence that trpE and trpA are the delimiting structural genes. Journal of Bacteriology. 108: 615-8. PMID 4941575 DOI: 10.1128/Jb.108.1.615-618.1971  0.379
1971 Rose JK, Yanofsky C. Transcription of the Operator Proximal and Distal Ends of the Tryptophan Operon: Evidence that trpE and trpA Are the Delimiting Structural Genes Journal of Bacteriology. 108: 615-618. DOI: 10.1128/jb.108.1.615-618.1971  0.373
1970 Rose JK, Mosteller RD, Yanofsky C. Tryptophan messenger ribonucleic acid elongation rates and steady-state levels of tryptophan operon enzymes under various growth conditions. Journal of Molecular Biology. 51: 541-50. PMID 4923859 DOI: 10.1016/0022-2836(70)90007-0  0.395
1970 Mosteller RD, Rose JK, Yanofsky C. Transcription Initiation and Degradation of trp mRNA Cold Spring Harbor Symposia On Quantitative Biology. 35: 461-466. DOI: 10.1101/Sqb.1970.035.01.060  0.378
Show low-probability matches.